Oxford BioMedica
Mary Rose Amato is a seasoned professional in quality systems and compliance, currently serving as Associate Director at Oxford Biomedica since June 2022. With a significant tenure at Sanofi from January 2013 to June 2022, Mary held various roles including Associate Director of Risk Management and Manager of Quality Compliance, demonstrating a strong foundation in quality assurance and regulatory adherence. Prior experience includes a position as Contract Test Services Analyst at Associates of Cape Cod, Inc. and a QC Chemistry Analyst role at Sanofi. Mary holds an educational background from Westfield State University.
This person is not in any teams
This person is not in any offices
Oxford BioMedica
2 followers
Oxford Biomedica (LSE: OXB) is a leading, fully integrated, cell and gene therapy group.